(Q37773378)

22 August 2017

1 reference

title

Inhibition of the renin-angiotensin system for prevention of atrial fibrillation (English)

1 reference

22 August 2017

0 references

Theodoros Zografos

1

1 reference

22 August 2017

Demosthenes G Katritsis

series ordinal

2

1 reference

22 August 2017

publication date

1 October 2010

1 reference

Pacing and Clinical Electrophysiology

22 August 2017

published in

1 reference

22 August 2017

volume

33

1 reference

22 August 2017

issue

10

1 reference

22 August 2017

page(s)

1270-1285

1 reference

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Gap junctions in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2010.02832.X

10.1111/J.1540-8159.2010.02832.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference